DAWN

DAWN EBITDA Margin

-66.70%TTM

Period ending:

DAWN FY EBITDA Margin%
DAWN FY EBITDA Margin8.00%-74.71%
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

DAWN ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Day One Biopharmaceuticals Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-66.7029%
-65.8145%
0%
0%
0%
0%
0%

Compare ebitda margin

All DAWN financial metrics · DAWN stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.